Noroclav 250 mg Tablets for dogs
Noroclav 250 mg Tablets for dogs
Authorised
- Potassium clavulanate
- Amoxicillin trihydrate
Product identification
Medicine name:
Noroclav 250 mg Tablets for dogs
Active substance:
- Potassium clavulanate
- Amoxicillin trihydrate
Target species:
-
Dog
-
Cat
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Potassium clavulanate59.56/milligram(s)1.00Tablet
-
Amoxicillin trihydrate229.61/milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01CR02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Available in:
-
Belgium
Package description:
- The product is supplied in high-density polyethylene tubs with a polyethylene screw cap lid containing 100 tablets.
- The product is supplied in high-density polyethylene tubs with a polyethylene screw cap lid containing 250 tablets.
- The product is presented in packs of 2 blister strips (aluminium-aluminium) each containing 5 tablets per strip.
- The product is presented in packs of 4 blister strips (aluminium-aluminium) each containing 5 tablets per strip.
- The product is presented in packs of 10 blister strips (aluminium-aluminium) each containing 5 tablets per strip.
- The product is presented in packs of 20 strips (aluminium-aluminium) each containing 5 tablets per strip.
- The product is also presented in packs of 50 blister strips (aluminium-aluminium) each containing 5 tablets per strip.
Additional information
Entitlement type:
-
Marketing Authorisation
Marketing authorisation holder:
- Norbrook Laboratories (Ireland) Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Norbrook Laboratories Limited
- Norbrook Manufacturing Limited
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0546/002
Concerned member states:
-
Austria
-
Belgium
-
Denmark
-
France
-
Luxembourg
-
Netherlands
-
Norway
-
Portugal
-
Spain
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
Combined File of all Documents
English (PDF)
Download Published on: 13/04/2025
Labelling
This document does not exist in this language (English). You can find it in another language below.
